Title: Modified tetrahalogenated benzimidazoles with CK2 inhibitory activity are active against human prostate cancer cells LNCaP in vitro.
Journal: Bioorganic & medicinal chemistry 20120715
Title: CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.
Journal: European journal of medicinal chemistry 20120101
Title: Facilitation of long-term potentiation by muscarinic M(1) receptors is mediated by inhibition of SK channels.
Journal: Neuron 20101209
Title: The selectivity of inhibitors of protein kinase CK2: an update.
Journal: The Biochemical journal 20081101
Title: Bollacke A, Nienberg C, Borgne ML, Jose J. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'. J Pharm Biomed Anal. 2016;121:253-260.
